It has been reported that high E2F1 or E2F4 activity in liposarcoma patients is associated with unfavorable prognosis, with the core target gene sets of E2F1 containing 116 genes and the core target gene sets of E2F4 containing 199 genes, among which only 21 are shared (30). This evidence concerns the gene E2F4 and liposarcoma.